康拓医疗
(688314)
| 流通市值：25.11亿 | | | 总市值：25.11亿 |
| 流通股本：8162.83万 | | | 总股本：8162.83万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 170,964,676.44 | 73,682,439.89 | 351,075,997.28 | 251,088,755.11 |
| 营业总成本 | 124,990,550.06 | 58,475,258.37 | 227,251,252.35 | 156,565,067.29 |
| 其他经营收益 | | | | |
| 营业利润 | 46,437,356.71 | 14,192,520.08 | 110,749,793.29 | 84,966,572.5 |
| 利润总额 | 46,692,812.73 | 14,306,438.84 | 115,519,538.84 | 89,724,401.4 |
| 净利润 | 40,403,700.69 | 12,666,303.04 | 97,748,316.83 | 75,906,135.43 |
| 每股收益 | | | | |
| 其他综合收益 | -378,935.79 | -286,265.89 | 3,482,497.86 | -753,129.35 |
| 综合收益总额 | 40,024,764.9 | 12,380,037.15 | 101,230,814.69 | 75,153,006.08 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 443,198,952.49 | 428,921,021.66 | 443,391,678.94 | 422,128,968.67 |
| 非流动资产: | | | | |
| 非流动资产合计 | 488,528,855.28 | 489,509,042.21 | 465,768,172.64 | 368,804,277.28 |
| 资产总计 | 931,727,807.77 | 918,430,063.87 | 909,159,851.58 | 790,933,245.95 |
| 流动负债: | | | | |
| 流动负债合计 | 101,605,175 | 99,492,433.77 | 105,073,037.22 | 86,818,833.48 |
| 非流动负债: | | | | |
| 非流动负债合计 | 77,612,036.36 | 77,949,865.05 | 80,046,258.42 | 13,768,435.43 |
| 负债合计 | 179,217,211.36 | 177,442,298.82 | 185,119,295.64 | 100,587,268.91 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 745,559,006.51 | 735,184,233.92 | 717,758,943.67 | 688,268,864.98 |
| 股东权益合计 | 752,510,596.41 | 740,987,765.05 | 724,040,555.94 | 690,345,977.04 |
| 负债和股东权益合计 | 931,727,807.77 | 918,430,063.87 | 909,159,851.58 | 790,933,245.95 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 204,949,247.25 | 89,445,147.88 | 390,528,201.14 | 287,099,764.83 |
| 经营活动现金流出小计 | 145,340,830.27 | 68,318,454.37 | 272,486,737.41 | 201,016,219.26 |
| 经营活动产生的现金流量净额 | 59,608,416.98 | 21,126,693.51 | 118,041,463.73 | 86,083,545.57 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 350,535,800.97 | 148,270,195.04 | 815,217,183.55 | 629,164,479.21 |
| 投资活动现金流出小计 | 477,345,151.03 | 353,483,051.38 | 931,584,732.01 | 822,211,010.22 |
| 投资活动产生的现金流量净额 | -126,809,350.06 | -205,212,856.34 | -116,367,548.46 | -193,046,531.01 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 15,439,618 | 0 | 30,000,000 | 0 |
| 筹资活动现金流出小计 | 29,094,704.85 | 1,242,380.78 | 35,970,512.56 | 33,577,694.13 |
| 筹资活动产生的现金流量净额 | -13,655,086.85 | -1,242,380.78 | -5,970,512.56 | -33,577,694.13 |
| 汇率变动对现金及现金等价物的影响 | -558,348.45 | -295,421.06 | -165,402.59 | -28,578.29 |
| 现金及现金等价物净增加额 | -81,414,368.38 | -185,623,964.67 | -4,461,999.88 | -140,569,257.86 |
| 期末现金及现金等价物余额 | 291,866,976.11 | 187,657,379.82 | 373,281,344.49 | 237,174,086.51 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -81,414,368.38 | - | -4,461,999.88 | - |